SCI Abstract

search
Chiral resolution of (R, S)-1-chloro-1-phenylethane by haloalkane dehalogenase DbjA in micro-aqueous phase
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 96fbf...
Design, synthesis, and biological evaluation of Pseudolaric acid B derivatives as Ferroptosis inducers in Colon Cancer cells
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 96fbf...
Kinsenoside derivatives mitigate acute liver injury in mice via MAPK pathway-mediated oxidative stress suppression
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 96fbf...
Further insights into the multitarget anticancer activity of tetrahydrocarbazole-1-amine/5-arylidene-4-thiazolinone based hybrids
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 96fbf...
Ultrasensitive chemiluminescent probe activated by NAG for real-time monitoring of AKI
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 96fbf...
An SPR-based active ingredient recognition strategy for identifying PLK1-targeting withanolides as natural ferroptosis inducers
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 96fbf...
Synthesis, antifungal activity, structure-activity relationship and mechanism of action of nicotinohydrazide derivatives
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 96fbf...
Exploring therapeutic strategies for candidiasis: From current treatments to future perspectives
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 96fbf...
Harnessing tyrosine kinase 2: Breakthroughs in autoimmune disease and cancer therapy
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 96fbf...
The LSD1/HDAC dual-target inhibitor for cancer therapy: Challenge and opportunity
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 96fbf...
Application of proteolysis targeting chimeric (PROTAC) technology in protein regulation and drug development
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 96fbf...
Chemotherapeutic potential of radotinib against blood and solid tumors: A beacon of hope in drug repurposing
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 8fb3b...
Rational design and syntheses of naphthalimide-based fluorescent probes for targeted detection of diabetes biomarkers
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 8fb3b...
An overview of phenylsulfonylfuroxan-based nitric oxide donors for cancer treatment
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 8fb3b...
Epidermal growth factor receptor mutations in breast Cancer: Therapeutic challenges and way forward
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 8fb3b...
Aldehyde dehydrogenases as drug targets for cancer: SAR and structural biology aspects for inhibitor design
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 8fb3b...
Thiazole – A promising scaffold for antituberculosis agents and structure–activity relationships studies
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 8fb3b...
TDP1 represents a promising therapeutic target for overcoming tumor resistance to chemotherapeutic agents: progress and potential
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 8fb3b...
Targeting XPO1 for fighting relapsed/refractory diseases: The research progress of XPO1 inhibitors
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 8fb3b...